| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Equipe dAccueil University Paris V and Department of Obstetrics (D.F., J.L.) and Department of Pediatric Endocrinology and U561 Institut National de la Santé et de la Recherche Médicale (P.B.), Hôpital Saint-Vincent de Paul, Hôpital Saint-Vincent de Paul, 75014 Paris, France; and Centre National de Génotypage (D.F., S.H., M.L.), 91057 Evry, France
Address all correspondence and requests for reprints to: Delphine Fradin, Institut National de la Santé et de la Recherche Médicale U561, Hôpital Saint-Vincent-de-Paul, 82 Avenue Denfert-Rochereau, 75014 Paris, France. E-mail: fradin{at}paris5.inserm.fr.
| Abstract |
|---|
|
|
|---|
Objective: The objective of the study was the mapping of quantitative trait loci (QTLs) for birth length and weight.
Design and Methods: To approach the genetic factors implicated in the normal variation of birth length and weight, we conducted a genome-wide approach of these two quantitative traits in 220 French Caucasian pedigrees (412 sibling pairs) using a variance components method.
Results: We observed evidence for several QTLs influencing birth length or birth weight independently. Whereas birth length and weight showed a close correlation (r = 0.76, P < 0.0001), their genetic variability appeared largely determined by distinct genomic loci. Birth length was influenced by two major QTLs located in 2p21 and 2q11 (LOD scores 2.69 and 3.57). The variability of birth weight was linked to another QTL on 7q35 (LOD score 3.1). Several other regions showed more modest evidence for linkage with LOD score values of 12 on chromosomes 7, 8, 10, 13, and 17 for birth length and chromosomes 1, 2, 6, 8, 10, 13, 14, 15, 17, and 20 for birth weight.
Conclusion: These preliminary QTLs provide a first step toward the identification of the genomic variants involved in the variability of human fetal growth. Our results should, however, be considered preliminary until they are replicated in other studies.
| Introduction |
|---|
|
|
|---|
Human physiology and monogenic diseases provide a few examples of genetic factors necessary to fetal growth. Genes regulating insulin secretion in mother and fetus (3) or IGF-I and IGF-II are important regulators of fetal growth (4). Also, the effects of duplications, uniparental disomies, or defects of imprinting (5) on fetal growth reveal the major importance of the parental origin of specific gene alleles in the 11p15.5 region (6). Other chromosomal disorders, including common trisomies of chromosomes 13, 18, and 21, as well as many duplications, deletions, and ring chromosomes are considered responsible for approximatively 20% of all intrauterine growth retardation cases through yet-unknown mechanisms. These observations indicate that the integrity of a vast number of yet-unknown genes is a requirement to normal fetal growth. The present work, however, is not a search for causes of genetic diseases of fetal growth but is instead an attempt to identify the genetic loci responsible for normal fetal growth variability.
Classical studies of resemblance within families demonstrate that genetic determinants influence normal fetal growth (7). According to epidemiological studies, environmental factors account for about 25% of birth weight variance and genetic factors for 3880% (8, 9). Within one generation (offspring of twins) in Norwegian families, model-fitting approaches suggest that fetal genes are responsible for more than half of the population variance in birth weight (9). There is, however, a considerable variability in the estimates of the participation of fetal (1869%) and parental (320%) genetic components to the variance of birth weight (10). The heritability of adult height varies between 70 and 80% (11, 12, 13), and birth length is somewhat correlated with paternal (r = 0.33) and maternal height (r = 0.26) (1). The heritability of birth length, however, has not been estimated to our knowledge. Knight et al. showed that quantitative trait loci (QTLs) for birth weight have been identified in other mammalian species, such as cattle (14, 15, 16), pigs, or a wild population of red deer (17). These QTLs, however, did not generate data that could be extrapolated at the gene level to the human species because of the yet-limited knowledge of these mammalian genomes. In humans, we reasoned that we did not have sufficient information about potential candidate genes regulating human growth to engage in fruitful association studies. This is why we elected a genome-wide random approach to find new loci. This method has recently allowed identification of QTLs on the human genome that were linked to birth weight in a Mexican-American cohort (18). We present here the preliminary results of a genome-wide attempt to localize the main QTLs influencing birth length and birth weight in a cohort of direct European ancestry.
| Subjects and Methods |
|---|
|
|
|---|
We selected families of European origin to reduce the extent of genetic heterogeneity, given the known importance of ethnic factors in the regulation of birth size (19). Family origin was carefully assessed by the analysis of paternal names and grandparents birth places. A cohort of families living in the Ile-de-France region was recruited in the Endocrinology Department of Saint Vincent de Paul Hospital (Paris V University) in which one of their children was followed up for overweight or obesity. Although birth weight and length were normal in all studied children, it could not be formally excluded that these families may be different from those ascertained without obesity. Clinical research procedures and genetic studies were approved by our institutional review board. All families signed informed consent documents before entering the study and completed a questionnaire about pregnancies; dietary habits; demographic factors; level of education; and family history of weight, height, obesity, and diabetes mellitus. Almost all children were born in hospitals and university hospitals surrounding Paris.
Inclusion criteria were: 1) a birth weight at term exceeding 2000 g (10 patients excluded) and less than 5000 g (four patients excluded); 2) gestational age strictly between 39 and 41 wk, determined by reference to the last menstrual period; 3) healthy gestation (mothers were considered healthy if they have no known diabetes, hypertension, medical condition, or known addiction associated with impaired fetal growth); 4) access to sampling at least one sibling; and 5) parental data and DNA available. The study population included 220 families, 154 pedigrees of two siblings, 53 pedigrees of three siblings, nine pedigrees of four siblings, three pedigrees of five siblings, and one pedigree of six siblings, leading to a total of 412 sibling pairs. The studied sample included 964 children who showed the same distribution of birth weight and birth length as the French general population and can therefore be considered a representative healthy sample of populations living on the European continent. Gestational age, length, and weight measurements were obtained from the Carnet de Santé filled by maternity pediatricians at birth. French children have to be precisely measured at birth to be included in the obligatory follow-up system of Carnet de Santé de lEnfance (Child Health Bulletin). The measurement of birth length had recently gained further precision because length at birth under 47 cm at term is now used as a threshold for the French social security system for GH treatment in short small-for-gestational age children. A log transformation was applied to birth weight and length data, followed by adjustment for the effect of sex and term. Birth weight and length were analyzed as continuous traits.
Genotyping
Forty milliliters of whole blood obtained from each family participant was frozen and stored at 20 C. Genomic DNA was extracted from the blood samples with an extraction kit (Gentra, Minneapolis, MN).
Genome scan
A genome scan with 418 markers at approximately 9-cM intervals was performed in 220 families by the Centre National de Génotypage. The 418 microsatellites were taken predominantly from Applied Biosystems Inc. (Foster City, CA). The linkage mapping set comprises 418 fluorescently labeled PCR primer pairs that define an approximately 10-cM resolution human index map. The loci were selected from the Généthon human linkage map based on chromosomal locations and heterozygosity. The map positions were generated from the CEPH genotype data used for the 1996 Généthon map. Full details on these markers and the genotyping procedures can be found elsewhere (https://products.appliedbiosystems.com/ab/en/US/adirect/ab?cmd=catNavigate2&catID=600776&tab=Literature).
Before linkage analysis, family structure informations and genomic markers were carefully analyzed to identify incorrect parentship assignment using PedCheck (20). We used the variance components model (21) implemented in Merlin for quantitative traits (22) to evaluate linkage to birth length and weight separately.
The variance component methods ignores detailed aspects of any model underlying the trait mode of inheritance and base inference on the correlation between relatives similarity with respect to the trait and their similarity with respect to one or more markers. Criteria for significance were based on guidelines published by Lander and Kruglyak (23) asserting that a LOD score greater than 3.6 indicates genome-wide significance, a LOD score between 2.2 and 3.6 indicates suggestive linkage, and LOD scores between 0.6 and 2.2 are nominal.
Simulations
We conducted 10,000 simulations to determine how many LOD scores would be found by simple chance over the thresholds of significance using our data and genomic markers. We simulated data using the same marker spacing, allele frequencies, missing data patterns, etc. as the real data, as described by Wiltshire et al. (24), implemented in Merlin. Each simulated data set was analyzed the same way as the real data set.
| Results |
|---|
|
|
|---|
|
Suggestive linkage was found on 10p15 and chromosome 2 (Fig. 2
). On chromosome 2, two peaks formed by six and 11 consecutive markers, respectively, showed a suggestive evidence for linkage to birth length (Table 1
). The first peak spans approximately 10 cM on 2p, with a LOD score maximum at D2S2259 (LOD 2.69, P = 2.104). The second peak spans approximately 12 cM on 2q, with a LOD score maximum at D2S2216 and D2S113 (LOD 3.57, P = 2.105), a value close to the genome-wide threshold of significance according to Lander and Kruglyak (23).
|
|
QTLs for birth weight
The highest LOD score of 3.1 (P = 8.105) was found on chromosome 7q on D7S2513 (Table 2
). Around this marker, three other markers gave a suggestive evidence for linkage to birth weight: D7S661, D7S498, and D7S2511. Several other regions showed peaks with a nominal LOD score (Fig. 3
), according to the criteria of Lander and Kruglyak (23). Twelve peaks with LOD scores between 1.0 and 2.2 were found on chromosomes 1p36-p35, 1q421q44, 2qter, 6q22-q24, 7p21-p11, 8p22, 10p12-p11, 13q31-q33, 14q11, 15q21, 17q24, and 20p13.
|
|
Multipoint linkage analysis for ponderal index (weight/height3) showed suggestive evidence for linkage in 6p21 (LOD = 2.18, P = 0.0008) and nominal evidence for linkage on chromosomes 9, between D9S285 and D9S161 (MLS = 1.51, P = 0.004), chromosome 10 (MLS = 0.82, P = 0.03), chromosome 13 (LOD = 1.23, P = 0.009), and chromosome 16 (MLS=1.22, P = 0.009) (data not shown).
Comparison of the identified QTL with those calculated from simulation tests
Ten thousand simulations indicated that six peaks with a LOD score of 1 or greater would be expected by chance, one with a LOD score of 2 or greater, and none with a LOD score of 3 or greater.
For birth length, we found that 10 loci located in six regions had a LOD score between 1 and 2. Twelve other LOD scores from four regions were between 2 and 3, and seven LOD scores were greater than 3, all of them located on 2q. The higher LOD score for length at birth reached 3.57.
For birth weight, we identified 39 QTLs located on 17 regions on 12 chromosomes whose LOD scores were between 1 and 2. Five LOD scores between 2 and 3 were found as three peaks on chromosomes 2, 7, and 10. We found only one LOD score greater than 3 on chromosome 7 for birth weight.
The genome scan for ponderal index allowed us to find eight LOD scores greater than 1 located within three regions on chromosomes 9, 13, and 16. A peak with a LOD score greater than 2 was identified on 6p (LOD = 2.18).
| Discussion |
|---|
|
|
|---|
Our analysis suggests that a locus on chromosome 2q11 (LOD 3.57) influences birth length strongly. Examination of the human genome sequence (International Human Genome Sequencing Consortium 2001) indicates a number of genes in this region, among which several could have physiological relevance, but we have no data to implicate these genes specifically.
Because the current genome scan was the first to investigate the genetics of birth length variability, we could not compare our results with other studies. It is interesting that several regions that we identified have already been implicated in the genetic regulation of adult height. Our QTL on chromosome 2q is somewhat reminiscent of those obtained in 379 sibling pairs from 58 families (Botnia cohort), in which a LOD score of 2.23 was found in the same region (26). Linkage to adult height was also found by previous studies on chromosomes 7q (27), 8p (26, 28, 29), 10q (30), and 17q (28, 31). Adult stature, although it shows a correlation with birth length (1), has a degree of complexity and variability that far exceeds those of birth length, and therefore, the QTLs apparently shared between adult height and birth length should be considered tentative.
Genomic loci linked to birth weight were different. The highest LOD score (3.1) for birth weight was on chromosome 7, near the D7S2513 marker. This region contains several genes that could be suspected to influence birth weight.
Another interesting linkage was found between birth weight and the 7p21-p11 region, which includes the glucokinase gene (32). Rare mutations of this gene influence birth weight when present in a mother and/or her offspring (3).
To our knowledge, only two genome scan linkage studies of birth weight have been performed in humans. In 269 Pima Amerindians, birth weight was analyzed as a discrete phenotype (i.e. low birth weight) (33). A significant evidence of linkage was found on chromosome 11 [at map position 88 cM, LOD (imprinting) = 3.4]. In this region, birth weight was predominantly linked to paternally derived alleles [LOD (fathers) = 4.1, LOD (mothers) = 0.0]. In 2006 another genome-wide scan linkage analyzed birth weight variability in Mexican-Americans from the San Antonio Family study, a population that is made of a recent admixture of Central America Amerindian and Caucasian populations (18). This study identified a major locus (LOD = 3.7) for birth weight on chromosome 6 and showed potential suggestive evidence for linkage on chromosomes 1, 2, 4, and 9. Our current linkage analysis did not show any linkage in these regions; neither were the QTLs of our study observed in the San Antonio study. These discrepancies as well as those cited before are common when linkage studies are compared and are generally attributed to variations in the genetic structure of the studied populations and the limited power of microsatellite-based linkage analysis of QTLs (34). The genome scan studies can also reflect differences owing to the contribution of genetics to the variation of birth weight in various populations (4, 5) and the varying environmental factors that may affect birth weight (35).
Our data were not confirmatory of earlier studies associating birth weight with INS-VNTR (11p15) (36, 37), H19 (11p15) (38), except for HLA DRB1 (6p21) (39). This may be due to discordance, or to the limited sensitivity of linkage studies compared with association studies at a specific gene locus (40).
Despite the strong phenotypic correlation between birth length and weight (Fig. 1
), we found that only one QTL on chromosome 8p22 appeared implicated in the variability of both birth length (LOD score 1.51) and weight (LOD score 1.81). It may be tempting to think that a specific locus within this QTL interval is a pleiotropic regulator of both skeleton length and fetal body mass, but the current data are still far from allowing us to substantiate this hypothesis. According to the same reasoning, the QTLs for ponderal index at birth reflect the genetic variability of birth weight when considered in proportion of birth length. The ponderal index may thus have a different genetic determination than birth weight per se.
For the other QTLs identified in this study, our observation that genetic loci controlling the variation in birth length and birth weight are distinct could simply reflect the fact that fetal growth recapitulates intricate but specific developmental processes, including the growth of brain (12% of birth weight) and head circumference (25% of birth length), the skeletal growth of limbs and spine, and the building of muscle and fat mass.
In any human genome scan study attempting to identify QTLs for multifactorial characters, there is a consistent risk of false positivity because most relevant LOD scores values are smaller than 3.6, the stringent threshold value for significance assigned by Lander and Kruglyak (23). The current results are no exception to this rule. To document the risk of false positivity attached to our genome scan, we performed simulation tests with our data. The comparison of these tests with our findings indicates that many found QTLs may reveal true localization for birth length, birth weight, or ponderal index. Nevertheless, it should be clearly understood that only fine mapping of suspected chromosome regions and replication in other cohorts will lead to bona fide localizations and help delineate the genomic regions implicated in human fetal growth variability.
| Acknowledgments |
|---|
| Footnotes |
|---|
First Published Online July 18, 2006
Abbreviation: QTL, quantitative trait loci.
Received March 9, 2006.
Accepted July 6, 2006.
| References |
|---|
|
|
|---|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |